ArticleBiomedicines2022

Viro-Immunological, Clinical Outcomes and Costs of Switching to BIC/TAF/FTC in a Cohort of People Living with HIV: A 48-Week Prospective Analysis.

Maria Mazzitelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.